south-korea-biomaterial-wound-dressing-market

South Korea Biomaterial Wound Dressing Market

South Korea Biomaterial Wound Dressing Market By Material (Collagen, Chitosan, Hyaluronic Acid, Alginate, Gelatin, Silk Fibroin, Synthetic Biomaterials), By Product: (Foam Dressings, Hydrogel Dressings, Hydrocolloid Dressings, Alginate Dressings, Collagen Dressings, Film Dressings, Composite Dressings), By Wound Type: (Chronic Wounds, Acute Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Surgical Wounds, Burns), By Application: (Wound Healing, Infection Prevention, Hemostasis, Tissue Regeneration, Exudate Management, Scar Management, Drug Delivery), By End User: (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, Long-Term Care Facilities, Wound Care Centers, Research Institutes) and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Analysis and Forecast 2026-2033

Report ID : 9667 | Publisher ID : Transpire | Published : Nov 2026 | Pages : 252 | Format: PDF/EXCEL

Revenue, 2025 USD 115.7 Million
Forecast, 2033 USD 231.7 Million
CAGR, 2026-2033 9.20%
Report Coverage South Korea

South Korea Biomaterial Wound Dressing Market Summary:

According to Transpire Insights, a detailed research report on the market reflects that the biomaterial product segment dominates the South Korea Biomaterial Wound Dressing Market, accounting for approximately USD 11.5 million in 2025 and projected to reach USD 18.7 million by 2033, registering a 6.3% CAGR from 2026 to 2033. Genewel Co., Ltd. leads the market with its prominent Medifoam® wound dressing portfolio and advanced biomaterial technologies, making it a leading contributor to market development, innovation, advanced biomaterial wound dressing production, expanding manufacturing capabilities, and growth dynamics.

Market Snapshot

  • Market Value (2025): USD 115.7 Million.
  • Expected Market Value (2026): USD 125.1 Million.
  • Estimated Market Value (2033): USD 231.7 Million.
  • Forecast CAGR (2026–2033): 9.20%

Introduction

The South Korea Biomaterial Wound Dressing Market is undergoing rapid changes due to the adoption of advanced wound care products that help to promote efficient healing and regeneration of tissues. The use of biomaterial wound dressings involves the application of biocompatible materials such as collagen, alginate, chitosan, hyaluronic acid, hydrogels, and sophisticated synthetic polymers to achieve appropriate moisture control, wound exudate management, protection, and wound repair. The main factors that are boosting the market development include the aging population of South Korea, the prevalence of chronic wounds, healthcare infrastructural development, and advanced medical technologies. The use of biomaterial wound dressings by hospitals and specialized providers is being carried out for diabetic ulcers, pressure injuries, surgery wounds, burns, and trauma wounds.

South Korea Biomaterial Wound Dressing Market Size

Key Market Highlights: -

  1. By Material, the Synthetic Biomaterials dominated the market and holds approximately 68% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
  2. By Product, the foam dressings dominated the market and holds approximately 28% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
  3. By Wound Type, the Chronic Wounds Manufacturers segment dominated the market and holds approximately 68% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
  4. The South Korea biomaterial wound dressing market is growing due to the aging population, innovations in regenerative biomaterials, development of health care infrastructure, government-funded research on medical devices, and regulatory changes.

How is Technology Driving Growth in the South Korea Biomaterial Wound Dressing Market?

Innovation in technologies such as smart technology, bioactive technology, antimicrobial technology, and regenerative wound care technology is facilitating market growth in the South Korea Biomaterial Wound Dressing Market. Smart technology and sensor technology help monitor the moisture levels, wound, and risk of infections. Bioactive biomaterials such as collagen, chitosan, hydrogels, and antimicrobial formulation increase exudate management and facilitate tissue regeneration. Electrospun fiber technology, collagen technology, and regenerative scaffold technology are being developed for next generation wound healing technologies. Digital wound monitoring helps in the clinical and remote monitoring of wounds and patients whereas advanced manufacturing and processing helps in the commercialization of these biomaterial wound dressings.

Market Drivers

South Korea Biomaterial Wound Dressing Market is driven by its fast aging population and the prevalence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and hard-to-treat wounds. Increasing use of innovative wound care technologies is pushing health care practitioners to adopt biomaterials that can provide better moisture control, exudate absorption, antimicrobial barriers, and biological benefits. The government-sponsored efforts in innovation in health care as well as investments by hospitals are promoting the uptake of regenerative and bioactive wound care technologies. Also, there are high levels of R&D activities in Korean biotech and medical devices companies for collagen, alginate, hydrogel, chitosan, and many more biomaterial dressing technologies.

Restrain

South Korea Biomaterial Wound Dressing Market restraints include low reimbursement for some high-end products, higher prices than traditional gauzes, and tough regulations. The expensive biomaterial dressings may hike up the costs of treatment and limit the use by smaller healthcare institutions and price-sensitive patients. Also, clinical testing and product approvals may delay the commercialization process especially for innovations such as collagen, hydrogel, alginate, chitosan, and regenerative biomaterial wound dressings.

Driver

Relative Impact on Growth (%)

Geographic Relevance

Impact Timeline

Demand Strength

Growth Mechanism

Key Beneficiaries

Major Constraint

Driver 1: Rising Chronic Wound and Aging-Related Care Demand

27%

Nationwide; Seoul Capital Area, Busan, Daegu

Short-term

High

Aging population increases chronic wound-management requirements

Biomaterial dressing manufacturers, hospitals, home-care providers

Reimbursement limitations for premium dressings

Driver 2: Adoption of Advanced Biomaterial and Bioactive Dressings

24%

Seoul, Gyeonggi, Daejeon; major tertiary hospitals

Medium-term

High

Bioactive materials accelerate healing and improve wound environments

Biomaterial developers, medical-device manufacturers, specialist clinics

High development and clinical-validation costs

Driver 3: Government Medical-Device R&D and Localization Investment

20%

Nationwide; technology and R&D clusters

Medium-term

High

Public R&D funding accelerates domestic biomaterial commercialization

Korean manufacturers, research institutes, technology suppliers

Long commercialization and regulatory cycles

Driver 4: Increasing Hospital Adoption of Advanced Wound Management

16%

Seoul, Gyeonggi, Busan, Incheon

Short-term

High

Hospitals shift toward dressings supporting faster and efficient wound closure

Hospitals, surgeons, wound-care specialists, dressing suppliers

Clinical preference and procurement-price pressures

Driver 5: Sustainable and Next-Generation Biomaterial Development

13%

Nationwide; Korean R&D and manufacturing hubs

Long-term

Medium

Biodegradable and regenerative materials create differentiated dressing products

Biomaterial companies, green-material suppliers, technology vendors

Scale-up complexity and material-cost volatility

Total

100%

—

—

—

—

—

—

Analysis of Prices and Consumer Behaviour

There is very high demand for advanced dressing products made using biomaterial technology among hospitals, chronic wound care, and specialized wound-care service providers. The advanced biomaterials represent about 11.5 million USD in 2025 due to the growing adoption of advanced technologies in wound care. Biomaterial dressings may be priced higher compared to normal gauzes because of the moisture management capabilities, absorbency of fluids, antiseptic and tissue regeneration properties. Foam dressings make up 40% of the overall advanced wound dressings, attributed to their flexible nature and exudate management capability. Hospitals account for about 55%, while chronic wounds account for nearly 50% of the applications. About 45% of the South Korean market is served by Seoul metropolitan area.

Company

Est. Revenue Share Range

Key Offerings

Strategic Positioning

Geographic Strength

Technology Focus

Genewel Co., Ltd.

10–15%

Medifoam®, Betafoam, moist wound dressings, biomaterial wound-care solutions

Domestic biomaterial leadership and product diversification

Asia Pacific, South Korea, selected export markets

Moist wound healing, polyurethane foam, biocompatible biomaterials

T&R Biofab Co., Ltd.

3–6%

Reprofoam, Bonofoam, VdECM hydrogel dressing, ECM-based wound products

Regenerative medicine-led innovation and differentiation

South Korea, Asia Pacific, emerging international markets

ECM biomaterials, hydrogels, 3D bioprinting, regenerative scaffolds

CGBio Inc.

3–6%

CG-PASTE, Easyfoam, CuraVAC, wound-management solutions

Regenerative biomaterials and integrated wound management

South Korea, Asia Pacific, Europe

Acellular dermal matrix, foam dressings, NPWT, regenerative biomaterials

L&C BIO Co., Ltd.

2–5%

MegaCure, MegaCare W, acellular dermal matrix products, skin-regeneration materials

Tissue-regeneration specialization with biomaterial breadth

South Korea, Asia Pacific, international markets

Acellular dermal matrix, collagen, bioabsorbable materials

HansBiomed Co., Ltd.

2–4%

ScarClinic™, Synthetic Biomaterials wound/scar dressings, tissue-regeneration biomaterials

Specialty biomaterials and scar-management differentiation

South Korea, Asia Pacific, Europe

Medical-grade Synthetic Biomaterials, scar management, regenerative biomaterials

ConvaTec Group Plc

7–11%

AQUACEL®, AQUACEL® Foam, AQUACEL® Ag+, DuoDERM®, Kaltostat®

Advanced dressing technology and clinical differentiation

Europe, North America, Asia Pacific

Hydrofiber®, hydrocolloid, alginate, antimicrobial dressings

Mölnlycke Health Care AB

6–10%

Mepilex®, Mepilex Ag®, Mepitel®, Exufiber®

Premium wound-care performance and clinical specialization

Europe, North America, Asia Pacific

Safetac®, Synthetic Biomaterials foam, antimicrobial and exudate management

Smith+Nephew Plc

6–10%

ALLEVYN®, ALLEVYN LIFE®, ALLEVYN Ag+, ALLEVYN COMPLETE CARE

Innovation-led advanced wound-management portfolio

North America, Europe, Asia Pacific

Hydrocellular foam, Synthetic Biomaterials, antimicrobial, exudate-locking technology

Solventum Corporation

5–9%

3M™ Tegaderm™, 3M™ Tegaderm™ Synthetic Biomaterials Foam, wound-care dressings

Broad clinical portfolio and hospital-channel strength

North America, Europe, Asia Pacific

Transparent films, Synthetic Biomaterials foam, adhesive and barrier technologies

B. Braun Melsungen AG

3–6%

Askina®, Askina® Foam, Askina® Hydro, Askina® Calgitrol®

Integrated hospital supply and value-based wound care

Europe, Asia Pacific, Latin America

Foam, hydrogel, alginate, antimicrobial wound technologies

Who are the Key Players in the South Korea Biomaterial Wound Dressing Market and how do they compete?

South Korea Biomaterial Wound Dressing Market competitiveness is provided by firms focused on innovations in the sphere of biomaterials, wound-care solutions, which are suitable for particular clinical application, and building up the distribution network worldwide. Competing not just due to low prices, but by means of developing wound dressings, biomaterial solutions, regenerative technology, and cooperation with the healthcare system, such type of competition results not only in continuous innovation of the product, but also enables to increase the healing efficiency, wound-management, effectiveness, and resource optimization in the healthcare organization.

With the help of developing advanced wound dressings, biomaterial solutions, regenerative technology, and wound-care products, Smith+Nephew becomes competitive in the market. With the help of producing high-performance wound-care products for chronic wounds, surgical wounds, exudate management, and other clinical applications, Mölnlycke Health Care distinguishes itself among its competitors. 3M positions itself by means of developing integrated solutions in advanced wound care, medical dressings, antimicrobial protection, and healthcare technologies.

Top Companies in the South Korea Biomaterial Wound Dressing Market

  1. Smith+Nephew
  2. Mölnlycke Health Care
  3. 3M
  4. Coloplast
  5. Convatec
  6. Integra LifeSciences
  7. Organogenesis
  8. B. Braun
  9. Medline Industries
  10. Hollister
  11. Cardinal Health
  12. Lohmann & Rauscher
  13. Daewoong Pharmaceutical
  14. Kolon Life Science
  15. Genewel

South Korea Biomaterial Wound Dressing Market Segmentation 

The South Korea Biomaterial Wound Dressing Market share is divided into five categories: By Material, By Product, By Wound Type, By Application, By End User

The Synthetic Biomaterials dominated the market, accounting for nearly 68% in 2025 and is expected to rise at a significant CAGR during the forecast period.

The South Korea Biomaterial Wound Dressing Market is segmented by material into collagen, chitosan, hyaluronic acid, alginate, gelatin, silk fibroin, synthetic biomaterials. Among these, the Synthetic Biomaterials segment dominated the market, accounting for nearly 68% in 2025 and expected to increase at a significant CAGR during the forecast period. The Synthetic Biomaterials market was leading in the South Korea Biomaterial Wound Dressing Market with almost 68% share in 2025 due to better durability, controlled performance, economical nature, and widespread clinical application.

The foam dressings dominated the market, accounting for nearly 28% in 2025, and is expected to rise at a significant CAGR during the forecast period.

The South Korea Biomaterial Wound Dressing Market is segmented by product into foam dressings, hydrogel dressings, hydrocolloid dressings, alginate dressings, collagen dressings, film dressings, composite dressings. Among these, the foam dressings dominated the market, accounting for nearly 28% in 2025 and expected to increase at a significant CAGR during the forecast period. This growth is attributed to better exudate absorption, moisture management, cushioning, longer wearing duration, and chronic wound care.

The Chronic Wounds dominated the market, accounting for nearly 68% in 2025 and is expected to rise at a significant CAGR during the forecast period.

The South Korea Biomaterial Wound Dressing Market is segmentedby wound type into chronic wounds, acute wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, surgical wounds, burns. Among these, the Chronic Wounds dominated the market, accounting for nearly 68% in 2025 and expected to increase at a significant CAGR during the forecast period. The factors driving the growth include increasing incidences of diabetes, aging wounds, healing needs, and the use of biomaterial dressings for effective chronic wound management.

South Korea Biomaterial Wound Dressing Market Type

Future Market Trends for the South Korea Biomaterial Wound Dressing Market:-

Intelligent and Bioactive Dressing: In South Korea, research on intelligent dressing that incorporates the use of sensors, bioactive materials, moisture sensing, antimicrobial properties, and drug delivery mechanisms is taking place.

Advanced Wound Treatment at Home: There has been an increased decentralization of healthcare, leading to higher demand for biomaterial wound dressing that can be used as outpatient care and home-based wound treatment.

Innovations with Biomaterials for Regeneration: Research and development within the country are becoming more centered on collagen, chitosan, hydrogels, composite biomaterials, and bioengineered skin.

Recent Development

In January-March 2026: South Korea fast-tracked the use of bioactive wound dressings, where innovations in collagen, chitosan, and alginate wound dressing became prominent for tissue regeneration and infections.

In April-June 2026: The research in smart wound dressings evolved due to the use of bioengineered materials that can track wound conditions and administer therapies accordingly.

In June 2026: There was an increase in the interest of healthcare professionals in home-based advanced wound dressing solutions, thus increasing demand for small and easy-to-use biomaterial dressings for chronic wounds.

In June 15, 2026: Launch of the Biomaterial Wound Dressing Market Size Report emphasizing the importance of natural and artificial biomaterials technologies and new market potentialities in the Asia-Pacific region.

Market Segmentation

This study forecasts revenue at Japan, regional and country levels from 2020 to 2033. Transpire Insights has segmented the South Korea Biomaterial Wound Dressing Market based on the below-mentioned segments:

South Korea Biomaterial Wound Dressing Market, By Material

  • Collagen
  • Chitosan
  • Hyaluronic Acid
  • Alginate
  • Gelatin
  • Silk Fibroin
  • Synthetic Biomaterials

South Korea Biomaterial Wound Dressing Market, By Product

  • Foam Dressings
  • Hydrogel Dressings
  • Hydrocolloid Dressings
  • Alginate Dressings
  • Collagen Dressings
  • Film Dressings
  • Composite Dressings

South Korea Biomaterial Wound Dressing Market, By Wound Type

  • Chronic Wounds
  • Acute Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Surgical Wounds
  • Burns

South Korea Biomaterial Wound Dressing Market, By Application

  • Wound Healing
  • Infection Prevention
  • Hemostasis
  • Tissue Regeneration
  • Exudate Management
  • Scar Management
  • Drug Delivery

South Korea Biomaterial Wound Dressing Market, By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Home Healthcare
  • Long-Term Care Facilities
  • Wound Care Centers
  • Research Institut’

Frequently Asked Questions

Find quick answers to common questions.

  1. Smith+Nephew
  2. Mölnlycke Health Care
  3. 3M
  4. Coloplast
  5. Convatec
  6. Integra LifeSciences
  7. Organogenesis
  8. B. Braun
  9. Medline Industries
  10. Hollister
  11. Cardinal Health
  12. Lohmann & Rauscher
  13. Daewoong Pharmaceutical
  14. Kolon Life Science
  15. Genewel

About the Authors

Pankaj Ghogare Patil -Author TI

Pankaj Ghogare Patil

I am Pankaj Ghogare Patil, a Senior Research Analyst at Transpire Insight, specializing in the Pharmaceutical, Chemicals & Materials, Healthcare IT, and Biotechnology industry. My expertise lies in conducting comprehensive market research, analyzing industry trends, evaluating competitive landscapes, and translating complex data into actionable insights. At Transpire Insight, I closely follow emerging technologies, regulatory developments, and market innovations to create accurate, well-researched, and informative content that helps businesses and professionals make informed decisions. I am committed to producing credible, evidence-based articles that reflect industry best practices while making technical topics accessible and valuable for a broad audience.

Chakradhar Khansole -Author TI

Chakradhar Khansole

Chakradhar serves as the Research Director at Transpire Insight, bringing over 8 years of experience in technology, innovation, and strategic market intelligence. He specializes in transforming complex market data into actionable business insights that enable organizations to make informed, growth-oriented decisions. Recognized for his strategic vision and analytical expertise, Chakradhar leads high-impact research initiatives, delivering comprehensive market assessments, competitive intelligence, and forward-looking industry analysis.

Recently Published Reports

Our Clients

client-logo_(1).jpg
client-logo.jpg
client-logo1.jpg
client-logo2.jpg
client-logo3.jpg
client-logo7.jpg
client-logo11.jpg
client-logo31.jpg